Treatment Of Hepatitis C In The Asian Population With Interferon-Beta
OwnerIan Parsons, Theodor Gininventors
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of IFN-beta in the manufacture of a medicament for the treatment of an HCV infection in a treatment-naïve patient belonging to the Asian population.
Claims17
1-16. (canceled)
A method of treatment of a interferon-α-naïve patient belonging to the Asian population with a hepatitis C virus (HCV) infection, comprising administering to the patient an effective amount of interferon-β (IFN-β), or a mutein, functional derivative, active fragment or fusion protein thereof, having IFN-β activity.
The use according to any of the preceding claims, wherein IFN-β is recombinant IFN-β.
A method of treatment of a interferon-α-naïve patient belonging to the Asian population with a hepatitis C virus (HCV) infection, comprising administering to the patient an effective amount of a pharmaceutical composition comprising interferon-β (IFN-β), or a mutein, functional derivative, active fragment or fusion protein thereof, having IFN-β activity, together with a pharmaceutically acceptable excipient.
Dependencies are inferred from the claim text.